286 related articles for article (PubMed ID: 19118029)
1. S100A2 induces metastasis in non-small cell lung cancer.
Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C
Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029
[TBL] [Abstract][Full Text] [Related]
2. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer.
Diederichs S; Bulk E; Steffen B; Ji P; Tickenbrock L; Lang K; Zänker KS; Metzger R; Schneider PM; Gerke V; Thomas M; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2004 Aug; 64(16):5564-9. PubMed ID: 15313892
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice.
Bulk E; Hascher A; Liersch R; Mesters RM; Diederichs S; Sargin B; Gerke V; Hotfilder M; Vormoor J; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2008 Mar; 68(6):1896-904. PubMed ID: 18339871
[TBL] [Abstract][Full Text] [Related]
5. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.
Feng G; Xu X; Youssef EM; Lotan R
Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825
[TBL] [Abstract][Full Text] [Related]
6. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma.
Tsai WC; Tsai ST; Jin YT; Wu LW
Mol Cancer Res; 2006 Aug; 4(8):539-47. PubMed ID: 16908593
[TBL] [Abstract][Full Text] [Related]
8. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
10. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
11. Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer.
Strazisar M; Rott T; Glavac D
Lung Cancer; 2009 Mar; 63(3):354-9. PubMed ID: 18656279
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
13. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
14. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.
Ito S; Kawano Y; Katakura H; Takenaka K; Adachi M; Sasaki M; Shimizu K; Ikenaka K; Wada H; Tanaka F
Lung Cancer; 2006 Jan; 51(1):79-88. PubMed ID: 16225959
[TBL] [Abstract][Full Text] [Related]
15. Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice.
Ogino H; Yano S; Kakiuchi S; Muguruma H; Ikuta K; Hanibuchi M; Uehara H; Tsuchida K; Sugino H; Sone S
Clin Cancer Res; 2008 Feb; 14(3):660-7. PubMed ID: 18245525
[TBL] [Abstract][Full Text] [Related]
16. S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy.
Bartling B; Rehbein G; Schmitt WD; Hofmann HS; Silber RE; Simm A
Eur J Cancer; 2007 Sep; 43(13):1935-43. PubMed ID: 17689067
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis.
Shintani Y; Higashiyama S; Ohta M; Hirabayashi H; Yamamoto S; Yoshimasu T; Matsuda H; Matsuura N
Cancer Res; 2004 Jun; 64(12):4190-6. PubMed ID: 15205330
[TBL] [Abstract][Full Text] [Related]
18. Identification of S100A2 as a target of the DeltaNp63 oncogenic pathway.
Hibi K; Fujitake S; Takase T; Kodera Y; Ito K; Akiyama S; Shirane M; Nakao A
Clin Cancer Res; 2003 Sep; 9(11):4282-5. PubMed ID: 14519656
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.
Fan T; Li R; Todd NW; Qiu Q; Fang HB; Wang H; Shen J; Zhao RY; Caraway NP; Katz RL; Stass SA; Jiang F
Cancer Res; 2007 Aug; 67(16):7901-6. PubMed ID: 17699796
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated antigen L6 and the invasion of human lung cancer cells.
Kao YR; Shih JY; Wen WC; Ko YP; Chen BM; Chan YL; Chu YW; Yang PC; Wu CW; Roffler SR
Clin Cancer Res; 2003 Jul; 9(7):2807-16. PubMed ID: 12855661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
